Medical Breakthrough In New Weight-loss Pill
Eli Lilly says a new pill for obesity, similar to existing GLP-1 medications that can only be injected, is showing promise in a clinical trial.
Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company’s new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults.
READ more from GMA: https://tinyurl.com/5dm9uz86
SUBSCRIBE to GMA on YouTube: https://bit.ly/2Zq0dU5
SIGN UP to get the daily GMA Wake-Up Newsletter:
https://tinyurl.com/yc34mz6t
VISIT GMA: https://www.goodmorningamerica.com
FOLLOW:
TikTok: https://tiktok.com/@gma
Instagram: https://instagram.com/GoodMorningAmerica
Facebook: https://facebook.com/GoodMorningAmerica
Threads: https://www.threads.net/@goodmorningamerica
X: https://twitter.com/gma
As seen on YouTube.
Related in [Weight loss]:
- The Weight Loss Scientist: You’ve Been LIED To About Calories, Dieting & Losing Weight: Giles Yeo
- Shonda Rhimes Discusses Her Dramatic Weight Loss
- Cientista Explica Determinantes Do Emagrecimento
- New Studies Look At Possible Weight Loss Pills
- Diet PLAN To Lose 10 KGS
Other posts:
- Brasil Tem 14.043.076 Casos Confirmados E 378.003 Mortes Por Coronavirus
- Say “Yuck” Or “Yum” To These 15 Dips And We’ll Reveal If You’re An Introvert, Extrovert, Or Ambivert
- THE BAD GUYS 2 | Official Trailer 2
- 🔴 Relaxing Music 24/7, Sleep Music, Stress Relief Music, Spa, Meditation, Yoga, Zen, Calming Music
- THE BIGGEST LIE IN THE FITNESS INDUSTRY FT. GREG DOUCETTE
